471 related articles for article (PubMed ID: 10838168)
1. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.
Routh RE; Johnson JH; McCarthy KJ
Kidney Int; 2002 Apr; 61(4):1365-76. PubMed ID: 11918743
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature.
Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD
Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose.
Ueta M; Wakisaka M; Ago T; Kitazono T; Nakamura U; Yoshinari M; Iwase M; Iida M
Kidney Int; 2004 Mar; 65(3):961-71. PubMed ID: 14871416
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
Nicholas SB; Kawano Y; Wakino S; Collins AR; Hsueh WA
Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363
[TBL] [Abstract][Full Text] [Related]
10. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
11. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells.
Ikeda U; Shimpo M; Murakami Y; Shimada K
Hypertension; 2000 Jun; 35(6):1232-6. PubMed ID: 10856269
[TBL] [Abstract][Full Text] [Related]
13. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
15. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
Aoun P; Simpkins JW; Agarwal N
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
[TBL] [Abstract][Full Text] [Related]
16. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells.
Schoppee PD; Garmey JC; Veldhuis JD
Biol Reprod; 2002 Jan; 66(1):190-8. PubMed ID: 11751282
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and hepatic stellate cell activation.
Miyahara T; Schrum L; Rippe R; Xiong S; Yee HF; Motomura K; Anania FA; Willson TM; Tsukamoto H
J Biol Chem; 2000 Nov; 275(46):35715-22. PubMed ID: 10969082
[TBL] [Abstract][Full Text] [Related]
18. Effect of PPARgamma ligands on the viability of gastric epithelial cells.
Kojima K; Shimada T; Mitobe Y; Yoshiura K; Hiraishi H; Terano A
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():67-73. PubMed ID: 11966526
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
20. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
